Company page

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated, trading under the ticker LGND, is a public company based in the United States with a market capitalization of approximately $5.5 billion. The company focuses on developing and commercializing technologies that enhance drug discovery and development. Ligand's innovative approach aims to provide solutions for pharmaceutical and biotechnology companies.

profileLGND:NASDAQAI content: aiUpdated June 24, 2026/company/ligand-pharmaceuticals-incorporated/c-jevnittq
Ligand Pharmaceuticals Incorporated logo
Ticker
LGND:NASDAQ
Asset type
Stock
Market cap
$5.51B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD